Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine vs Vasopressin for Hemorrhage Reduction in Myomectomy
NCT01861015Phase 3Completed
- Sponsor
- CHA University
- Start
- May 2013
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of epinephrine in uterine leiomyoma, sponsored by CHA University. Primary endpoint: Operative blood loss. Started May 2013; status: completed.
02
Drugs
epinephrine
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT01861015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01861015.